Luigia Vetrone
YOU?
Author Swipe
View article: Efficacy and Safety of Epidermal Radionuclide Therapy with <sup>188</sup> Re Resin in Patients with Nonmelanoma Skin Cancers: Long-Term Data from a Single Center
Efficacy and Safety of Epidermal Radionuclide Therapy with <sup>188</sup> Re Resin in Patients with Nonmelanoma Skin Cancers: Long-Term Data from a Single Center Open
Nonmelanoma skin cancer (NMSC) occurs in photoexposed areas and is frequent in the elderly population. Surgical excision remains the treatment of choice whenever feasible. However, alternative approaches are clinically important for patien…
View article: Unsealed 188Rhenium Resin Brachytherapy in Non-Surgical Candidates With Refractory Basal Cell Carcinoma: Clinical Outcomes
Unsealed 188Rhenium Resin Brachytherapy in Non-Surgical Candidates With Refractory Basal Cell Carcinoma: Clinical Outcomes Open
Introduction: High-dose brachytherapy using a non-sealed 188Rhenium resin (188Re) is a new treatment option for difficult-to-treat basal cell carcinoma (BCC), that ensures a radical oncological outcome minimizing side effects. Objectives: …
View article: Unsealed<sup>188</sup> Rhenium Resin Brachytherapy in Non-Surgical Candidates With Refractory Basal Cell Carcinoma: Clinical Outcomes.
Unsealed<sup>188</sup> Rhenium Resin Brachytherapy in Non-Surgical Candidates With Refractory Basal Cell Carcinoma: Clinical Outcomes. Open
High-dose 188Re brachytherapy is a noninvasive, easy to perform, well-tolerated approach to treat difficult BCC when surgery or other therapy techniques are not feasible.
View article: Feasibility of<sup>177</sup>Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer
Feasibility of<sup>177</sup>Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer Open
View article: [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT–Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging
[<sup>68</sup>Ga]Ga-PSMA-11 PET/CT–Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging Open
No abstract available.
View article: Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection Open
Introduction Prostate-specific membrane antigen (PSMA) is a transmembrane protein expressed by normal prostatic tissue. Therefore, molecular imaging targeting PSMA (PSMA-PET) has gained particular interest and diffusion for PCa staging and…
View article: Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT? Open
View article: A novel tool for predicting the dose distribution of non‐sealed <sup>188</sup>Re (Rhenium) resin in non‐melanoma skin cancers (NMSC) patients
A novel tool for predicting the dose distribution of non‐sealed <sup>188</sup>Re (Rhenium) resin in non‐melanoma skin cancers (NMSC) patients Open
Background High‐dose rate brachytherapy using a non‐sealed 188 Rhenium resin ( 188 Re) is a recently approved treatment option for non‐melanoma skin cancer (NMSC). The treatment goal is to deliver a personalized absorbed dose to the deepes…
View article: Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging Open
PSMA-PET/CT is a suitable replacement for conventional imaging in the primary staging of PCa. The aim of this retrospective study was to assess the correlation between parameters discovered by PSMA PET/CT in primary staging and either pros…
View article: Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge Open
This is a case of [ 68 Ga]Ga-Prostate-specific membrane antigen (PSMA)-11 PET/CT in a 73-years old patient presenting high Prostate Specific Antigen (PSA) levels despite both multi-parametric magnetic resonance imaging (mpMRI) and 12-core …